Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY4N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,491
Award facts
- Contract value 100% obligated
- $11,490.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,490.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens (2 mL) on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, where the vendor's corporate office is located. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order represents a task order issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., maintains an even larger IDC with DLA valued at $999,999,999.00 through December 31, 2031. DUPIXENT (dupilumab) is a biologic medication used to treat atopic dermatitis, eosinophilic esophagitis, and asthma, making this procurement consistent with DLA's mission to supply comprehensive pharmaceutical products across multiple therapeutic domains to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCY4N?
SPE2DR26FCY4N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY4N worth?
The government has obligated $11,491 on SPE2DR26FCY4N.
Is contract SPE2DR26FCY4N an order under another contract?
Yes. SPE2DR26FCY4N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY4N competed?
The extent of competition for SPE2DR26FCY4N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award